Summary
Signal counts
Assets tracked: 1
Watchlist assets: 1
Registry stop assets: 0
Sponsor overview
Peking University Cancer Hospital & Institute
Public clinical-program risk signals across linked oncology Phase 2 assets for this sponsor.
Evidence links
Public sources
https://clinicaltrials.gov/study/NCT02878057 | https://clinicaltrials.gov/study/NCT02544737 | https://clinicaltrials.gov/study/NCT03520257
Assets
Linked programs
- Apatinib: Timeline Staleness Signal (4/5)